-1.8 C
New York
Tuesday, January 22, 2019
- Advertisement -

Featured Authors

Editor's Pick

TC BioPharm creates allogeneic cell banks for CAR-T cancer therapy products

GLASGOW, Scotland--(BUSINESS WIRE)--TC BioPharm (TCB), a developer of CAR-T immuno-oncology products, including Gamma Delta T (GDT) cell therapies, today announced it has completed formulation...

U.S. insulin costs per patient nearly doubled from 2012 to 2016:...

The cost of insulin for treating type 1 diabetes in the United States nearly doubled over a five-year period, underscoring a national outcry over rising drug prices, according to a new analysis shared with Reuters.

Financial News


Research and Dev

New Podcast

Trends in The New Value-Based Reimbursement Model